Efficacy and safety of ruxolitinib in regularly transfused patients with thalassemia: Results from a phase 2a study

Ali T. Taher, Zeynep Karakas, Elena Cassinerio, Noppadol Siritanaratkul, Antonis Kattamis, Aurelio Maggio, Stefano Rivella, Norbert Hollaender, Bruyere Mahuzier, Brian Gadbaw, Yesim Aydinok

Research output: Contribution to journalLetter

Original languageEnglish
Pages (from-to)263-265
Number of pages3
JournalBlood
Volume131
Issue number2
DOIs
Publication statusPublished - Jan 11 2018

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Cite this